Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia - Y.-A. Que; H. Lazar; M. Wolff; B. François; P.-F. Laterre; E. Mercier; J. Garbino; J.-L. Pagani; J.-P. Revelly; E. Mus; A. Perez; M. Tamm; et al. (European Journal of Clinical Microbiology & Infectious Diseases, 2014)